Home/Filings/4/0001104659-24-084933
4//SEC Filing

Amin Naseem 4

Accession 0001104659-24-084933

CIK 0001012477other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:35 PM ET

Size

7.6 KB

Accession

0001104659-24-084933

Insider Transaction Report

Form 4
Period: 2024-07-30
Amin Naseem
Director
Transactions
  • Award

    Ordinary Shares

    2024-07-30+11,00011,000 total
  • Award

    Stock Option (Right to Buy)

    2024-07-30+11,00011,000 total
    Exercise: $16.32Exp: 2034-07-30Ordinary Shares (11,000 underlying)
Footnotes (2)
  • [F1]Represents restricted share units ("RSUs"). Each RSU represents the contingent right to receive one Ordinary Share upon vesting and settlement. The RSUs shall vest in full on the earlier to occur of (a) July 30, 2025 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time.
  • [F2]The options shall vest in full on the earlier to occur of (a) July 30, 2025 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time.

Issuer

AVADEL PHARMACEUTICALS PLC

CIK 0001012477

Entity typeother

Related Parties

1
  • filerCIK 0001646754

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:35 PM ET
Size
7.6 KB